Click for best price
Endometriosis Drugs Market Size, Share 2022
Endometriosis affects an estimated 1 in 10 women in the reproductive age group of 15-49 years.
This report contains market size and forecasts of Endometriosis Drugs in Global, including the following market information:
Global top five companies in 2021 (%)
The global Endometriosis Drugs market was valued at 1909.9 million in 2021 and is projected to reach US$ 2246.3 million by 2028, at a CAGR of 2.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hormonal Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Endometriosis Drugs include AbbVie, Astellas Pharma, AstraZeneca, Debiopharm Group, Evotec, Kissei Pharmaceutical, Neurocrine Biosciences, ObsEva and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Endometriosis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Endometriosis Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Endometriosis Drugs Market Segment Percentages, by Type, 2021 (%)
- Hormonal Therapy
- Add-back Medication
- Progestogens
- Chinese Herbs
Global Endometriosis Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Endometriosis Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinics
- Research Institutes
Global Endometriosis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Endometriosis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Endometriosis Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Endometriosis Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AbbVie
- Astellas Pharma
- AstraZeneca
- Debiopharm Group
- Evotec
- Kissei Pharmaceutical
- Neurocrine Biosciences
- ObsEva
- Pfizer
- Repros Therapeutics
- Roivant Sciences
- Takeda Pharmaceutical Company
- ValiRx
| Report Attributes |
Report Details |
| Report Title |
Endometriosis Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Endometriosis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Endometriosis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Endometriosis Drugs Overall Market Size
2.1 Global Endometriosis Drugs Market Size: 2021 VS 2028
2.2 Global Endometriosis Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Endometriosis Drugs Players in Global Market
3.2 Top Global Endometriosis Drugs Companies Ranked by Revenue
3.3 Global Endometriosis Drugs Revenue by Companies
3.4 Top 3 and Top 5 Endometriosis Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Endometriosis Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Endometriosis Drugs Players in Global Market
3.6.1 List of Global Tier 1 Endometriosis Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Endometriosis Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Endometriosis Drugs Market Size Markets, 2021 & 2028
4.1.2 Hormonal Therapy
4.1.3 Add-back Medication
4.1.4 Progestogens
4.1.5 Chinese Herbs
4.2 By Type - Global Endometriosis Drugs Revenue & Forecasts
4.2.1 By Type - Global Endometriosis Drugs Revenue, 2017-2022
4.2.2 By Type - Global Endometriosis Drugs Revenue, 2023-2028
4.2.3 By Type - Global Endometriosis Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Endometriosis Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Research Institutes
5.2 By Application - Global Endometriosis Drugs Revenue & Forecasts
5.2.1 By Application - Global Endometriosis Drugs Revenue, 2017-2022
5.2.2 By Application - Global Endometriosis Drugs Revenue, 2023-2028
5.2.3 By Application - Global Endometriosis Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Endometriosis Drugs Market Size, 2021 & 2028
6.2 By Region - Global Endometriosis Drugs Revenue & Forecasts
6.2.1 By Region - Global Endometriosis Drugs Revenue, 2017-2022
6.2.2 By Region - Global Endometriosis Drugs Revenue, 2023-2028
6.2.3 By Region - Global Endometriosis Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Endometriosis Drugs Revenue, 2017-2028
6.3.2 US Endometriosis Drugs Market Size, 2017-2028
6.3.3 Canada Endometriosis Drugs Market Size, 2017-2028
6.3.4 Mexico Endometriosis Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Endometriosis Drugs Revenue, 2017-2028
6.4.2 Germany Endometriosis Drugs Market Size, 2017-2028
6.4.3 France Endometriosis Drugs Market Size, 2017-2028
6.4.4 U.K. Endometriosis Drugs Market Size, 2017-2028
6.4.5 Italy Endometriosis Drugs Market Size, 2017-2028
6.4.6 Russia Endometriosis Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Endometriosis Drugs Market Size, 2017-2028
6.4.8 Benelux Endometriosis Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Endometriosis Drugs Revenue, 2017-2028
6.5.2 China Endometriosis Drugs Market Size, 2017-2028
6.5.3 Japan Endometriosis Drugs Market Size, 2017-2028
6.5.4 South Korea Endometriosis Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Endometriosis Drugs Market Size, 2017-2028
6.5.6 India Endometriosis Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Endometriosis Drugs Revenue, 2017-2028
6.6.2 Brazil Endometriosis Drugs Market Size, 2017-2028
6.6.3 Argentina Endometriosis Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Endometriosis Drugs Revenue, 2017-2028
6.7.2 Turkey Endometriosis Drugs Market Size, 2017-2028
6.7.3 Israel Endometriosis Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Endometriosis Drugs Market Size, 2017-2028
6.7.5 UAE Endometriosis Drugs Market Size, 2017-2028
7 Players Profiles
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Endometriosis Drugs Major Product Offerings
7.1.4 AbbVie Endometriosis Drugs Revenue in Global Market (2017-2022)
7.1.5 AbbVie Key News
7.2 Astellas Pharma
7.2.1 Astellas Pharma Corporate Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Endometriosis Drugs Major Product Offerings
7.2.4 Astellas Pharma Endometriosis Drugs Revenue in Global Market (2017-2022)
7.2.5 Astellas Pharma Key News
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Endometriosis Drugs Major Product Offerings
7.3.4 AstraZeneca Endometriosis Drugs Revenue in Global Market (2017-2022)
7.3.5 AstraZeneca Key News
7.4 Debiopharm Group
7.4.1 Debiopharm Group Corporate Summary
7.4.2 Debiopharm Group Business Overview
7.4.3 Debiopharm Group Endometriosis Drugs Major Product Offerings
7.4.4 Debiopharm Group Endometriosis Drugs Revenue in Global Market (2017-2022)
7.4.5 Debiopharm Group Key News
7.5 Evotec
7.5.1 Evotec Corporate Summary
7.5.2 Evotec Business Overview
7.5.3 Evotec Endometriosis Drugs Major Product Offerings
7.5.4 Evotec Endometriosis Drugs Revenue in Global Market (2017-2022)
7.5.5 Evotec Key News
7.6 Kissei Pharmaceutical
7.6.1 Kissei Pharmaceutical Corporate Summary
7.6.2 Kissei Pharmaceutical Business Overview
7.6.3 Kissei Pharmaceutical Endometriosis Drugs Major Product Offerings
7.6.4 Kissei Pharmaceutical Endometriosis Drugs Revenue in Global Market (2017-2022)
7.6.5 Kissei Pharmaceutical Key News
7.7 Neurocrine Biosciences
7.7.1 Neurocrine Biosciences Corporate Summary
7.7.2 Neurocrine Biosciences Business Overview
7.7.3 Neurocrine Biosciences Endometriosis Drugs Major Product Offerings
7.7.4 Neurocrine Biosciences Endometriosis Drugs Revenue in Global Market (2017-2022)
7.7.5 Neurocrine Biosciences Key News
7.8 ObsEva
7.8.1 ObsEva Corporate Summary
7.8.2 ObsEva Business Overview
7.8.3 ObsEva Endometriosis Drugs Major Product Offerings
7.8.4 ObsEva Endometriosis Drugs Revenue in Global Market (2017-2022)
7.8.5 ObsEva Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Endometriosis Drugs Major Product Offerings
7.9.4 Pfizer Endometriosis Drugs Revenue in Global Market (2017-2022)
7.9.5 Pfizer Key News
7.10 Repros Therapeutics
7.10.1 Repros Therapeutics Corporate Summary
7.10.2 Repros Therapeutics Business Overview
7.10.3 Repros Therapeutics Endometriosis Drugs Major Product Offerings
7.10.4 Repros Therapeutics Endometriosis Drugs Revenue in Global Market (2017-2022)
7.10.5 Repros Therapeutics Key News
7.11 Roivant Sciences
7.11.1 Roivant Sciences Corporate Summary
7.11.2 Roivant Sciences Business Overview
7.11.3 Roivant Sciences Endometriosis Drugs Major Product Offerings
7.11.4 Roivant Sciences Endometriosis Drugs Revenue in Global Market (2017-2022)
7.11.5 Roivant Sciences Key News
7.12 Takeda Pharmaceutical Company
7.12.1 Takeda Pharmaceutical Company Corporate Summary
7.12.2 Takeda Pharmaceutical Company Business Overview
7.12.3 Takeda Pharmaceutical Company Endometriosis Drugs Major Product Offerings
7.12.4 Takeda Pharmaceutical Company Endometriosis Drugs Revenue in Global Market (2017-2022)
7.12.5 Takeda Pharmaceutical Company Key News
7.13 ValiRx
7.13.1 ValiRx Corporate Summary
7.13.2 ValiRx Business Overview
7.13.3 ValiRx Endometriosis Drugs Major Product Offerings
7.13.4 ValiRx Endometriosis Drugs Revenue in Global Market (2017-2022)
7.13.5 ValiRx Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Endometriosis Drugs Market Opportunities & Trends in Global Market
Table 2. Endometriosis Drugs Market Drivers in Global Market
Table 3. Endometriosis Drugs Market Restraints in Global Market
Table 4. Key Players of Endometriosis Drugs in Global Market
Table 5. Top Endometriosis Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Endometriosis Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Endometriosis Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Endometriosis Drugs Product Type
Table 9. List of Global Tier 1 Endometriosis Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Endometriosis Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Endometriosis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Endometriosis Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Endometriosis Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Endometriosis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Endometriosis Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Endometriosis Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Endometriosis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Endometriosis Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Endometriosis Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Endometriosis Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Endometriosis Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Endometriosis Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Endometriosis Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Endometriosis Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Endometriosis Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Endometriosis Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Endometriosis Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Endometriosis Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Endometriosis Drugs Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Endometriosis Drugs Product Offerings
Table 32. AbbVie Endometriosis Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Astellas Pharma Corporate Summary
Table 34. Astellas Pharma Endometriosis Drugs Product Offerings
Table 35. Astellas Pharma Endometriosis Drugs Revenue (US$, Mn), (2017-2022)
Table 36. AstraZeneca Corporate Summary
Table 37. AstraZeneca Endometriosis Drugs Product Offerings
Table 38. AstraZeneca Endometriosis Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Debiopharm Group Corporate Summary
Table 40. Debiopharm Group Endometriosis Drugs Product Offerings
Table 41. Debiopharm Group Endometriosis Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Evotec Corporate Summary
Table 43. Evotec Endometriosis Drugs Product Offerings
Table 44. Evotec Endometriosis Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Kissei Pharmaceutical Corporate Summary
Table 46. Kissei Pharmaceutical Endometriosis Drugs Product Offerings
Table 47. Kissei Pharmaceutical Endometriosis Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Neurocrine Biosciences Corporate Summary
Table 49. Neurocrine Biosciences Endometriosis Drugs Product Offerings
Table 50. Neurocrine Biosciences Endometriosis Drugs Revenue (US$, Mn), (2017-2022)
Table 51. ObsEva Corporate Summary
Table 52. ObsEva Endometriosis Drugs Product Offerings
Table 53. ObsEva Endometriosis Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Endometriosis Drugs Product Offerings
Table 56. Pfizer Endometriosis Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Repros Therapeutics Corporate Summary
Table 58. Repros Therapeutics Endometriosis Drugs Product Offerings
Table 59. Repros Therapeutics Endometriosis Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Roivant Sciences Corporate Summary
Table 61. Roivant Sciences Endometriosis Drugs Product Offerings
Table 62. Roivant Sciences Endometriosis Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Takeda Pharmaceutical Company Corporate Summary
Table 64. Takeda Pharmaceutical Company Endometriosis Drugs Product Offerings
Table 65. Takeda Pharmaceutical Company Endometriosis Drugs Revenue (US$, Mn), (2017-2022)
Table 66. ValiRx Corporate Summary
Table 67. ValiRx Endometriosis Drugs Product Offerings
Table 68. ValiRx Endometriosis Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Endometriosis Drugs Segment by Type in 2021
Figure 2. Endometriosis Drugs Segment by Application in 2021
Figure 3. Global Endometriosis Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Endometriosis Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Endometriosis Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Endometriosis Drugs Revenue in 2021
Figure 8. By Type - Global Endometriosis Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Endometriosis Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Endometriosis Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Endometriosis Drugs Revenue Market Share, 2017-2028
Figure 12. US Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Endometriosis Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Endometriosis Drugs Revenue Market Share, 2017-2028
Figure 24. China Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Endometriosis Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Endometriosis Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Endometriosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Endometriosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Astellas Pharma Endometriosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AstraZeneca Endometriosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Debiopharm Group Endometriosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Evotec Endometriosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Kissei Pharmaceutical Endometriosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Neurocrine Biosciences Endometriosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. ObsEva Endometriosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Endometriosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Repros Therapeutics Endometriosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Roivant Sciences Endometriosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Takeda Pharmaceutical Company Endometriosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. ValiRx Endometriosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
